Carbon-based nanomaterials are a kind of attractive photothermal
agents (PTAs) for tumor photothermal therapy (PTT). However, their
inherent fluorescent emission always compromises the photothermal
conversion efficiency and is a huge obstruction that needs to be solved.
Herein, a kind of hemoglobin (Hb)-decorated boron-carbon nanosheets
(BC NSs) was designed and developed with catalytic ability and near-infrared
II light-responsive performance for photoacoustic (PA) imaging-guided
synergistic tumor PTT/chemodynamic therapy (CDT). BC NSs were synthesized
from biomass gelatin, coated with a polydopamine (PDA) layer, and
decorated with Fenton agent Hb. The formed BC-PDA-Hb (BCPH) NSs had
no fluorescent emission, high photothermal conversion performance
(47.8% under 1064 nm laser irradiation), and excellent PA imaging
capability. The Fe2+ carried in Hb can react with intratumoral
overexpressed H2O2 to generate toxic hydroxyl
radicals. In vitro and in vivo data
revealed that BCPH NSs can achieve effective tumor elimination through
synergistic PTT/CDT without detectable adverse effects on normal tissues.
This work offers an effective strategy to develop carbon-based nanomedicines
owning promoted photothermal performance and high biocompatibility
for tumor theranostic applications.